icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
eNq1mF1v2jAUhu/5FVEudkdCCqF0S0AbKxtSqzFatGk3yCSHYhbs1B9A++vnELrSyVFXgy8TJ+859jl+/MpRb7vKnDUwjimJ3cBruA6QhKaY3MXu5HZQ77i9bi1aojU6+Ozca3jBmeskGeI8dotRbwaIcO/n9dVnUP8Dc7s1J6KzJSTixXdS4Mz7ivjiGuXFN060pjh1ViAWNI3dXIrdWyfigqksuhvKfvMcJRD5+zeHo8tp6/B95Bdi/6EqObArRO60okCMNBPJGBDRRwLuKHuoyLdppI35GDiVLIEREosRo2ucQqoNMUcZB6Mg8016A2ydgSiCaMX9ZbLiRuJoibZjuB/qk/6oRvtiK+qNenAetsIw7DQvmq2OUSh2sFT6KqhJ+Mk0aLaDi3bDB+ITWCOCEsPajCgTKLNUFcz7LxvLUhwG969WP8U8z9CDt+S56VIhhtQwMLX97U2kmMEtU0DK1Jr9o09klvlvzHqyx4WljAsa9akkooIag7HpQvQpEbCtrqgZ6MR234sY+OlkHynRQ34kZxlOTJGmoCOBi8l4WE20U8LgE+IwYfZo8AOTlG746SlzWFVL2ec7UGpFc5YG07OLTjsIQ+NN9Eu1UMUJcykZzcFX/MH8GKwMyZweCxTVlXqpp548WTvufA5NUAYVTqduyBbVh0/GzFqn29tF5YBW9MvlrWl7fJfAHm52j1ppnMZ/C2sGXhs0V834WuLlto3zabMRdpQte4dW+YcnCx0b2uVS1IpblkzPmIUQOX/v+5vNxlsgXudIrac3Z9VnQE879VNMXwH3uZr2DL0VA1AaohK2llKflafo28pounFfswjH2t79/3t7rY0hmIQjalEy3hqJh5enh/uz57WW9ugFYuyF2flTJDAltnyTnGkVjztOVF3JgClAfJvPccUFS2VfRn55udOtRX5xsdOt/QGjVAAV
Z9RpSX6P0esBmMTx
Listen
